Dynocardia
Newton Centre, US · Founded 2018 · Delaware corporation
Dynocardia develops ViTrack, a wearable and connected platform for continuous monitoring of blood pressure and other vital heart and lung functions. The technology targets applications across hospitals, clinical practice, remote patient monitoring, and consumer wellness.
Founders & leadership
Dynocardia was founded in 2018 by Mohan Thanikachalam.
MT
Mohan ThanikachalamFounder
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 4 rounds · 2019–2025
▶$1.2MraisedDec 2025 · 20 investors · Other Health CareRule 506(b)
▶$1.2MraisedDec 2025 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohan ThanikachalamExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.2M
- Sales commissions
- $74.4K
- Finders' fees
- $24.8K
- Placement agents
- American Trust Investment Services, Inc.
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedJan 2025 · 35 investors · Other Health CareRule 506(b)
▶$3.7MraisedJan 2025 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohan ThanikachalamExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3.7M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJan 2021 · 19 investors · Other Health CareRule 506(b)
▶$2MraisedJan 2021 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohan ThanikachalamExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- Sales commissions
- $12.5K
- Placement agents
- Revere Securities LLC
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$490KraisedOct 2020 · 7 investors · Other Health CareRule 506(b)
▶$490KraisedOct 2020 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohan ThanikachalamExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $490K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Topera4 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Zendesk3 shared keywordsThis is Zendesk's internal belonging/diversity and inclusion program page, not a company profile page for an external company. It describes Zendesk's internal culture initiatives and leadership development programs.
SymKardia3 shared keywordsSymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.
Companies competing with Dynocardia for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dynocardia do?
- Dynocardia develops ViTrack, a wearable and connected platform for continuous monitoring of blood pressure and other vital heart and lung functions. The technology targets applications across hospitals, clinical practice, remote patient monitoring, and consumer wellness.
- Who founded Dynocardia?
- Dynocardia was founded by Mohan Thanikachalam in 2018.
- How much funding has Dynocardia raised?
- Dynocardia has disclosed $7.4M raised across 4 rounds.
- Where is Dynocardia headquartered?
- Dynocardia is headquartered in Newton Centre, US.